By the end of the year, 100 million vaccines for SARS-CoV-2 will be created. Production will start before the tests are completed

The American National Institute of Allergy and Infectious Diseases has just announced that by the end of the year, the United States will have 100 million vaccines for SARS-CoV-2 coronavirus. Their production will start before the end of clinical trials.

The plan was presented by the director of the National Institute of Allergy and Infectious Diseases and a member of the White House task force for coronavirus - Dr. Anthony Fauci. It is a vaccine from Moderna mRNA-1273 , which was designed with the virus proteins responsible for infecting human cells in mind.

Coronavirus vaccine

After its administration, the immune system of vaccinated people will develop appropriate antibodies in advance, which will make SARS-CoV-2 unable to attach itself to humans.

In the first phase of clinical testing, the desired vaccine effect was observed in eight volunteers. Fauci announced that the final stage of clinical testing of mRNA-1273 vaccine will start around mid-summer. In this last, third phase of the study, the vaccine will be given to a very diverse group of 30,000. volunteers.

The point is, of course, to check whether the preparation created by Moderna turns out to be safe both when it comes to young and healthy people, as well as for older representatives of society suffering from chronic diseases.

"This will be the whole spectrum, " says Fauci and adds that the second phase of clinical trials started a few days ago with the participation of several hundred volunteers.

Mass production of the coronavirus vaccine before testing

The National Institute of Allergy and Infectious Diseases has recommended a plan that assumes Moderna will begin mass production of mRNA-1273 before the end of the third phase of research. It is a bit risky play, but if it works, Moderna should make it by the end of the year with the production of about 100 million. portions of the vaccine.

Only research on its effectiveness and whether its administration does not cause any undesirable side effects should end at the end of the year - according to Fauci it will be November or December. If everything goes according to plan, the Americans will have tested and ready to give the vaccine in early 2021.

However, if during the third phase of clinical tests any undesirable and dangerous side effects are revealed, tens of millions of portions of mRNA-1273 will be suitable only for disposal. Risky. Neither Moderna nor Fauci have spoken a word about distribution of the vaccine in Europe yet. I suspect that the manufacturer will focus primarily on the United States.

The persistence of the immune response after vaccine administration remains a separate issue. People develop antibodies to fight the common cold caused by other strains of coronavirus, but this protection usually lasts about a year. This may mean that you will need to get a new vaccine every year, just as you would for the flu.

Do not miss new texts. Follow Spider's Web in Google News .



By the end of the year, 100 million vaccines for SARS-CoV-2 will be created. Production will start before the tests are completed

Comments

Popular posts from this blog

What is VoLTE and how can you activate it on your Xiaomi

So you can check the battery status of your Xiaomi smartphone and how many cycles you have performed

How to exit the FASTBOOT mode of your Xiaomi if you have entered accidentally

Does your Xiaomi charge slowly or intermittently? So you can fix it

Problems with Android Auto and your Xiaomi? So you can fix it

If your Xiaomi disconnects only from the WiFi it may be because of that MIUI setting

How to change the font in MIUI and thus further customize your Xiaomi: so you can change the type, color and size of the letters of MIUI

What is the Safe Mode of your Xiaomi, what is it for and how can you activate it

Improve and amplify the volume of your Xiaomi and / or headphones with these simple adjustments

How to activate the second space if your Xiaomi does not have this option